Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2022-02-15 11:36:30
With reference to the stock exchange announcement from SoftOx Solutions AS
(SoftOx) on 8 February 2022, the webcast presentation, due to take place on 16
February 2022, has been postponed due to Covid among the management. The Q4 2021
results will be made available on www.soft-ox.com and www.newsweb.no on
Wednesday, 16 February 2022.
The webcast presentation by management will take place Monday 28th February
2022, at 13:00 (CET).
Date: Monday, 28th February
Time: 13:00 - 14:00
RSVP: Registration to corporateaccess@sb1markets.no
For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine Rød of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
BioTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com